Compounds > farnesol

farnesol and epidermal growth factor

farnesol has been researched along with epidermal growth factor in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (62.50)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ayukawa, K; Isobe, H; Nawata, H; Sakai, H; Satoh, T1
Carel, K; Draznin, B; Goalstone, M; Kline, T; Leitner, JW1
Ben-Baruch, G; Egozi, Y; Gana-Weisz, M; Haklai, R; Kloog, Y; Marciano, D1
Braquet, P; Cousse, H; Mencia-Huerta, JM; Paubert-Braquet, M; Raynaud, JP1
Ben-Baruch, G; Egozi, Y; Gana-Weisz, M; Giehl, K; Gierschik, P; Kloog, Y; Marciano, D; Weisz, B1
Fan, P; Li, Y; Santen, RJ; Wang, J; Yue, W1
Amos, S; Hussaini, IM; McPheson, R; Polar, G; Redpath, GT; Schiff, D1
Charette, N; De Saeger, C; Horsmans, Y; Lannoy, V; Leclercq, I; Stärkel, P1

Other Studies

8 other study(ies) available for farnesol and epidermal growth factor

ArticleYear
The effects of pravastatin, an HMG-CoA reductase inhibitor, on cell viability and DNA production of rat hepatocytes.
    Life sciences, 1996, Volume: 59, Issue:14

    Topics: Adenine; Animals; Apoptosis; Cell Survival; Cells, Cultured; Cholesterol, LDL; Chromatin; DNA; Enzyme Inhibitors; Epidermal Growth Factor; Farnesol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isopentenyladenosine; Liver; Male; Mevalonic Acid; Pravastatin; Rats; Rats, Wistar

1996
Hyperinsulinemia potentiates activation of p21Ras by growth factors.
    Endocrinology, 1997, Volume: 138, Issue:5

    Topics: 3T3 Cells; Alkyl and Aryl Transferases; Animals; Drug Synergism; Enzyme Inhibitors; Epidermal Growth Factor; Farnesol; Farnesyltranstransferase; Growth Substances; Guanosine Triphosphate; Insulin; Insulin-Like Growth Factor I; Mice; Organophosphonates; Organophosphorus Compounds; Protein Prenylation; Proto-Oncogene Proteins p21(ras); Transferases

1997
The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation.
    Biochemical and biophysical research communications, 1997, Oct-29, Volume: 239, Issue:3

    Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; DNA Replication; DNA, Neoplasm; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; Farnesol; Humans; Proto-Oncogene Proteins c-raf; ras Proteins; Rats; Retroviridae Proteins, Oncogenic; Salicylates; Thrombin; Thymidine; Tumor Cells, Cultured

1997
Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsies.
    European urology, 1998, Volume: 33, Issue:3

    Topics: Acyclic Monoterpenes; Androgen Antagonists; Cell Division; Cells, Cultured; Epidermal Growth Factor; Farnesol; Fibroblast Growth Factor 2; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Plant Extracts; Prostate; Prostatic Hyperplasia; Serenoa; Terpenes

1998
A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice.
    Oncogene, 1999, Apr-22, Volume: 18, Issue:16

    Topics: Animals; Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activation; Epidermal Growth Factor; Farnesol; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; ras Proteins; Salicylates; Tumor Cells, Cultured

1999
Farnesylthiosalicylic acid blocks mammalian target of rapamycin signaling in breast cancer cells.
    International journal of cancer, 2005, Dec-10, Volume: 117, Issue:5

    Topics: Apoptosis; Blood; Breast Neoplasms; Cell Division; Cell Line, Tumor; DNA Replication; Enzyme Activation; Epidermal Growth Factor; Estradiol; Farnesol; Humans; Insulin-Like Growth Factor I; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Kinases; Ribosomal Protein S6 Kinases; Salicylates; Signal Transduction; TOR Serine-Threonine Kinases

2005
Farnesylthiosalicylic acid induces caspase activation and apoptosis in glioblastoma cells.
    Cell death and differentiation, 2006, Volume: 13, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Caspases; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Farnesol; Glioblastoma; Humans; Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; ras Proteins; Salicylates; Signal Transduction; Time Factors

2006
Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
    Molecular cancer, 2010, Sep-22, Volume: 9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cyclin A; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Farnesol; Female; Hep G2 Cells; Humans; Inhibitor of Apoptosis Proteins; Insulin-Like Growth Factor II; Liver Neoplasms; Mice; Mice, Nude; Microtubule-Associated Proteins; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; Salicylates; Survivin; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2010